Positron emission tomography agent 2-deoxy-2-[<Superscript>18</Superscript>F]fluoro-D-glucose has a therapeutic potential in breast cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer

Authors:	Renee?M?Moadel,Andrew?V?Nguyen,Elaine?Y?Lin,Ping?Lu,Joseph?Mani,M?Donald?Blaufox,Jeffrey?W?Pollard,Ekaterina?Dadachova author-information" > author-information__contact u-icon-before" > mailto:edadacho@aecom.yu.edu" title=" edadacho@aecom.yu.edu" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author

Affiliation:	(1) Department of Nuclear Medicine, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA;(2) Department of Microbiology and Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA;(3) Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, USA;

Abstract:	Background Novel approaches are needed for breast cancer patients in whom standard therapy is not effective. 2-Deoxy-2-[¹⁸F]fluoro-D-glucose (¹⁸F-FDG) was evaluated as a potential radiomolecular therapy agent in breast cancer animal models and, retrospectively, in patients with metastatic breast cancer.

Keywords:
本文献已被 PubMed SpringerLink 等数据库收录！